Total Payments
$278,510
2024 Payments
$46,615
Companies
20
Transactions
260
Payment Breakdown by Category
Consulting$158,069 (56.8%)
Travel$46,912 (16.8%)
Other$39,890 (14.3%)
Research$27,817 (10.0%)
Food & Beverage$5,823 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $158,069 | 68 | 56.8% |
| Travel and Lodging | $46,912 | 67 | 16.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,390 | 9 | 14.1% |
| Unspecified | $27,817 | 16 | 10.0% |
| Food and Beverage | $5,823 | 99 | 2.1% |
| Grant | $500.00 | 1 | 0.2% |
Payments by Type
General
$250,694
244 transactions
Research
$27,817
16 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ablative Solutions, Inc. | $66,722 | 30 | $0 (2023) |
| Medtronic, Inc. | $49,326 | 55 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $41,055 | 24 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $28,771 | 18 | $0 (2024) |
| Astellas Pharma Europe BV | $19,875 | 8 | $0 (2018) |
| Medtronic Vascular, Inc. | $19,521 | 61 | $0 (2020) |
| Janssen Research & Development, LLC | $18,577 | 16 | $0 (2023) |
| UROVANT SCIENCES INC | $10,045 | 3 | $0 (2022) |
| Shire North American Group Inc | $9,294 | 5 | $0 (2018) |
| BOSTON SCIENTIFIC CORPORATION | $5,700 | 13 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46,615 | 35 | IDORSIA PHARMACEUTICALS US INC ($28,019) |
| 2023 | $36,612 | 44 | Medtronic, Inc. ($18,090) |
| 2022 | $36,787 | 31 | Medtronic, Inc. ($14,870) |
| 2021 | $39,050 | 23 | Ablative Solutions, Inc. ($28,471) |
| 2020 | $23,589 | 18 | Regeneron Pharmaceuticals, Inc. ($11,900) |
| 2019 | $37,416 | 28 | Janssen Research & Development, LLC ($18,401) |
| 2018 | $27,076 | 40 | Shire North American Group Inc ($9,294) |
| 2017 | $31,365 | 41 | Astellas Pharma Europe BV ($18,875) |
All Payment Transactions
260 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8,740.00 | General |
| Category: Hypertension | ||||||
| 12/23/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,415.00 | General |
| Category: Hypertension | ||||||
| 12/13/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Travel and Lodging | In-kind items and services | $419.05 | General |
| Category: Renal Denervation System | ||||||
| 12/13/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Travel and Lodging | In-kind items and services | $35.07 | General |
| Category: Renal Denervation System | ||||||
| 12/11/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,980.00 | General |
| Category: Hypertension | ||||||
| 12/08/2024 | Kyowa Kirin Co., Ltd | — | Food and Beverage | In-kind items and services | $86.45 | General |
| 12/07/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Travel and Lodging | In-kind items and services | $218.80 | General |
| Category: Hypertension | ||||||
| 12/06/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Travel and Lodging | In-kind items and services | $229.95 | General |
| Category: Hypertension | ||||||
| 12/03/2024 | Stryker Corporation | EVEREST SPINAL SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $169.86 | General |
| Category: SPINE | ||||||
| 12/03/2024 | Stryker Corporation | N/A (Device) | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: NAVIGATION | ||||||
| 12/02/2024 | Stryker Corporation | N/A (Device) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: NAVIGATION | ||||||
| 11/25/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,440.00 | General |
| Category: Hypertension | ||||||
| 11/16/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Travel and Lodging | In-kind items and services | $262.98 | General |
| Category: Hypertension | ||||||
| 11/16/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Travel and Lodging | In-kind items and services | $218.48 | General |
| Category: Hypertension | ||||||
| 10/28/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Consulting Fee | Cash or cash equivalent | $1,140.00 | General |
| Category: Hypertension | ||||||
| 10/28/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Travel and Lodging | In-kind items and services | $853.58 | General |
| Category: Hypertension | ||||||
| 10/09/2024 | Corcept Therapeutics | Korlym (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,275.00 | General |
| Category: Endocrinology | ||||||
| 09/30/2024 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 09/06/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $124.44 | General |
| Category: Endocrinology | ||||||
| 08/05/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Consulting Fee | Cash or cash equivalent | $1,520.00 | General |
| Category: Hypertension | ||||||
| 07/26/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $130.24 | General |
| Category: Cardiology | ||||||
| 07/18/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | — | Cash or cash equivalent | $2,082.50 | Research |
| Study: A RANDOMIZED, DOUBLE-MASKED, ACTIVE-CONTROLLED PHASE 2/3 STUDY OF THE EFFICACY AND SAFETY OF HIGH-DOSE AFLIBERCEPT IN PATIENTS WITH DIABETIC MACULAR EDEMA • Category: OPHTHALMOLOGY | ||||||
| 03/26/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $47.24 | General |
| Category: Pacemakers | ||||||
| 03/10/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $176.15 | General |
| Category: Renal Denervation System | ||||||
| 03/01/2024 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $9,253.50 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-MASKED, ACTIVE-CONTROLLED PHASE 2/3 STUDY OF THE EFFICACY AND SAFETY OF HIGH-DOSE AFLIBERCEPT IN PATIENTS WITH DIABETIC MACULAR EDEMA | Regeneron Pharmaceuticals, Inc. | $15,916 | 8 |
| A Randomized, Double-Masked, Active-Controlled Phase 2/3 Study of the Efficacy and Safety of High-Dose Aflibercept in Patients With Diabetic Macular Edema | Regeneron Pharmaceuticals, Inc. | $11,900 | 8 |
About Dr. Michael Weber, MD
Dr. Michael Weber, MD is a Specialist healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2009. The National Provider Identifier (NPI) number assigned to this provider is 1346472792.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Weber, MD has received a total of $278,510 in payments from pharmaceutical and medical device companies, with $46,615 received in 2024. These payments were reported across 260 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($158,069).
Ad
Practice Information
- Specialty Specialist
- Location New York, NY
- Active Since 08/19/2009
- Last Updated 09/03/2014
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346472792
Products in Payments
- Tryvio (Drug) $28,019
- EYLEA (Biological) $21,569
- Myrbetriq (Drug) $18,875
- APROCITENTAN $12,861
- GEMTESA (Drug) $10,045
- EYLEA HD (Biological) $6,248
- CLINICAL TRIAL PRODUCT (Device) $4,800
- RESOLUTE ONYX (Device) $3,716
- Korlym (Drug) $2,399
- MYRBETRIQ (Drug) $1,000
- GENERAL - THERAPIES (Device) $900.00
- SYMPLICITY G3 (Device) $630.27
- QUVIVIQ (Drug) $174.93
- EVEREST SPINAL SYSTEM (Device) $169.86
- CARTO 3 (Device) $130.24
- Visia AF (Device) $128.91
- AZURE XT DR MRI SURESCAN (Device) $83.96
- Resolute (Device) $82.89
- ELIQUIS (Drug) $74.19
- ENTRESTO (Drug) $67.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in New York
Dr. Eric Rose, M.d, M.D
Specialist — Payments: $4.9M
Specialist $4.9M
Dr. Baron Lonner, M.d, M.D
Specialist — Payments: $2.9M
Specialist $2.9M
Dr. Richard Spaide, Md, MD
Specialist — Payments: $1.7M
Specialist $1.7M
Dr. Marla Dubinsky, M.d, M.D
Specialist — Payments: $1.6M
Specialist $1.6M
Mrs. Naomi Nakao, M.d, M.D
Specialist — Payments: $1.1M
Specialist $1.1M
Dr. Janice Dutcher, M.d, M.D
Specialist — Payments: $994,054
Specialist $994,054